Search

everythinglearnresearchcommunity

for

Search:↓

Current drug safety systems fail to detect long-term side effects, leading to preventable health issues.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Current drug safety systems fail to detect long-term side effects, needing improvements to protect health and trust.

The safety of the hair loss drug finasteride is unclear due to inadequate reporting in clinical trials.

Post-drug syndromes are often overlooked, and better systems and education are needed to improve drug safety.

CT scans can find serious prostate cancer even when PSA levels are low.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Syphilis can mimic other diseases, making diagnosis challenging, but proper testing and treatment are effective.

New hair and skin changes were found in a rare case of syphilis-related hair loss.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Men may experience long-term sexual dysfunction after stopping Finasteride.

The document's conclusion cannot be provided because the content is not accessible.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Inconsistent safety reporting in chronic back pain trials risks patient safety and decision-making.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Finasteride, a hair loss drug, has unaddressed sexual side effects due to the manufacturer's inadequate safety measures and lack of additional studies.

Clinicians need to better understand and treat Post-finasteride syndrome.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

A man with HIV had an unusual syphilis rash that looked like folliculitis but was cured with penicillin.

TURP specimens should be checked for various tumors, not just common prostate issues.

Hair loss in secondary syphilis is more common than thought and can be reversed with antibiotics.

Ketoconazole improved symptoms of ACTH-independent Cushing syndrome despite inconclusive initial scans.

Most patients with Tuberous sclerosis had neurological or skin issues, and over half had psychiatric problems.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Finasteride use is strongly linked to sexual dysfunction, especially in young men treating hair loss.

Timely and aggressive treatment is crucial for improving outcomes in severe complications of adult-onset Still's disease.